Julen Cadinanos
Overview
Explore the profile of Julen Cadinanos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bailon L, Molto J, Curran A, Cadinanos J, Carlos Lopez Bernaldo de Quiros J, de Los Santos I, et al.
Nat Commun
. 2025 Mar;
16(1):2146.
PMID: 40038256
Building on results from the AELIX-002 trial with HIVACAT T-cell immunogen (HTI)-based vaccines, the AELIX-003 (NCT04364035) trial tested the safety of the combination of ChAdOx1.HTI (C) and MVA.HTI (M), with...
2.
Cadinanos J, Rodriguez-Centeno J, Montejano R, Esteban-Cantos A, Mena-Garay B, Jimenez-Gonzalez M, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae550.
PMID: 39416992
Background: People with HIV-1 (PWH) age differently than the general population. Blood telomere length (BTL) attrition is a surrogate biomarker of immunosenescence and aging in PWH. BTL is reduced immediately...
3.
Alonso-Navarro R, Ramirez M, Masia M, Paredes R, Montejano R, Povar-Echeverria M, et al.
BMC Infect Dis
. 2023 May;
23(1):286.
PMID: 37142994
Background: Shorter duration of symptoms before remdesivir has been associated with better outcomes. Our goal was to evaluate variables associated with the need of ICU admission in a cohort of...
4.
de Miguel R, Rial-Crestelo D, Dominguez-Dominguez L, Montejano R, Esteban-Cantos A, Aranguren-Rivas P, et al.
EBioMedicine
. 2023 Feb;
89:104486.
PMID: 36806001
No abstract available.
5.
Esteban-Cantos A, Rodriguez-Centeno J, Silla J, Barruz P, Sanchez-Cabo F, Saiz-Medrano G, et al.
EBioMedicine
. 2023 Jan;
88:104434.
PMID: 36640455
Background: Previous epigenome-wide association studies have shown that HIV infection can disrupt the host DNA methylation landscape. However, it remains unclear how antiretroviral therapy (ART) affects the HIV-induced epigenetic modifications....
6.
de Miguel Buckley R, Rial-Crestelo D, Montejano R, Pinto A, Jimenez-Gonzalez M, Lagarde M, et al.
Open Forum Infect Dis
. 2022 Nov;
9(11):ofac610.
PMID: 36447613
In this pilot clinical trial, we evaluated rates of residual replication in persons without lamivudine resistance-associated mutations in proviral DNA population sequencing who switched to dolutegravir plus lamivudine. After 144...
7.
Bendala-Estrada A, Diaz-Almiron M, Busca C, Mican R, Cadinanos J, Montes M, et al.
HIV Med
. 2022 Nov;
24(5):558-567.
PMID: 36394195
Introduction: The use of tenofovir alafenamide (TAF) has been associated with increased cholesterol and body weight. Real-life data on the metabolic effects of switching from a TAF-based triple regimen to...
8.
Mican R, de Gea Grela A, Cadinanos J, de Miguel R, Busca C, Bernardino J, et al.
AIDS
. 2022 Jul;
36(14):1941-1947.
PMID: 35848506
Introduction: Few clinical trials and cohort studies have evaluated the efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in people with HIV (PWH) with preexisting M184V/I or other nucleos(t)ide reverse transcriptase inhibitor (NRTI)...
9.
Rodes B, Cadinanos J, Esteban-Cantos A, Rodriguez-Centeno J, Arribas J
EBioMedicine
. 2022 Mar;
77:103896.
PMID: 35228014
The antiretroviral treatment (ART) developed to control HIV infection led to a revolution in the prognosis of people living with HIV (PLWH). PLWH underwent from suffering severe disease and often...
10.
Rodriguez-Centeno J, Esteban-Cantos A, Montejano R, Stella-Ascariz N, de Miguel R, Mena-Garay B, et al.
J Antimicrob Chemother
. 2022 Jan;
77(4):1125-1132.
PMID: 35045162
Objectives: To evaluate whether the negative impact of tenofovir on telomere length (TL) is due to immune reconstitution interference or inhibition of telomerase. Methods: One hundred and twenty-eight long-term aviraemic...